Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Schizophrenia is a devastating neurodevelopmental disorder whose genetic influences remain elusive. We hypothesize that individually rare structural variants contribute to the illness. Microdeletions and microduplications >100 kilobases were identified by microarray comparative genomic hybridization of genomic DNA from 150 individuals with schizophrenia and 268 ancestry-matched controls. All variants were validated by high-resolution platforms. Novel deletions and duplications of genes were present in 5% of controls versus 15% of cases and 20% of young-onset cases, both highly significant differences. The association was independently replicated in patients with childhood-onset schizophrenia as compared with their parents. Mutations in cases disrupted genes disproportionately from signaling networks controlling neurodevelopment, including neuregulin and glutamate pathways. These results suggest that multiple, individually rare mutations altering genes in neurodevelopmental pathways contribute to schizophrenia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, a rare CNV for ERBB4 has been identified in schizophrenia46.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [46]
In the citing paper
“In addition, rare but highly penetrant CNVs have been found in many genes encoding synaptic proteins46.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [46]
In the citing paper
“Early findings from our group observed a 3-fold enrichment of rare genic CNVs in cases as compared with controls (Walsh et al., 2008).”
From CNVs: Harbingers of a Rare Variant Revolution in Psychiatric Genetics (2012) · cites this paper as Walsh et al., 2008
In the citing paper
“Early on, it was apparent that rare CNVs tended to impact genes involved in neuronal function (Walsh et al., 2008). These included functional categories related to synaptic activity and neurodevelopment (Malhotra et al., 2011; Walsh et al., 2008).”
From CNVs: Harbingers of a Rare Variant Revolution in Psychiatric Genetics (2012) · cites this paper as Walsh et al., 2008
In the citing paper
“While the strength of evidence supporting specific pathways differs between data sets, we do find evidence consistent with our earlier observations that there is an enrichment of “neurodevelopmental” and “synaptic” genes among rare CNVs in SCZ (Walsh et al., 2008).”
From High frequencies of de novo CNVs in bipolar disorder and schizophrenia (2011) · cites this paper as Walsh et al., 2008
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Detection of large-scale variation in the human genome
Iafrate, A. J., Feuk, L., Rivera, M. N., Listewnik, M. L., Donahoe, P. K., Qi, Y., Scherer, S. W., & Lee, C. (2004) · Nature Genetics · doi:10.1038/ng1416 · Cited by 2,892
Strong association of de novo copy number mutations with autism
Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., Yamrom, B., Yoon, S., Krasnitz, A., Kendall, J., et al. (2007) · Science · doi:10.1126/science.1138659 · Cited by 2,795
Self-citationSchizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Lohmueller, K. E., Pearce, C. L., Pike, M., Lander, E. S., & Hirschhorn, J. N. (2003) · Nature Genetics · doi:10.1038/ng1071 · Cited by 1,900
Association between Microdeletion and Microduplication at 16p11.2 and Autism
Weiss, L. A., Shen, Y., Korn, J. M., Arking, D. E., Miller, D. T., Fossdal, R., Saemundsen, E., Stefansson, H., Ferreira, M. A. R., Green, T., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa075974 · Cited by 1,666
Mapping autism risk loci using genetic linkage and chromosomal rearrangements
The Autism Genome Project Consortium (2007) · Nature Genetics · doi:10.1038/ng1985 · Cited by 1,402
Segmental Duplications and Copy-Number Variation in the Human Genome
Sharp, A. J., Locke, D. P., McGrath, S. D., Cheng, Z., Bailey, J. A., Vallente, R. U., Pertz, L. M., Clark, R. A., Schwartz, S., Segraves, R., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/431652 · Cited by 972
Self-citationRecurrent 16p11.2 microdeletions in autism
Kumar, R. A., KaraMohamed, S., Sudi, J., Conrad, D. F., Brune, C., Badner, J. A., Gilliam, T. C., Nowak, N. J., Cook, E. H., Dobyns, W. B., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm376 · Cited by 731
Genomic Disorders: Molecular Mechanisms for Rearrangements and Conveyed Phenotypes
Lupski, J. R., & Stankiewicz, P. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010049 · Cited by 582
The DISC locus in psychiatric illness
Chubb, J. E., Bradshaw, N. J., Soares, D. C., Porteous, D. J., & Millar, J. K. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002106 · Cited by 542
Research works printed but not linked: 4
- G. Kirovet al., Hum. Mol. Genet.17, 458 (2008).
- National Center for Biotechnology Information National Library of Medicine Bethesda MD www.ncbi.nlm.nih.gov.
- K. M. Giehl, Prog. Exp. Tumor Res.39, 1 (2007).
- N. Nortonet al., Am. J. Med. Genet. B Neuropsychiatr. Genet.141, 96 (2006).
Cited by
Items 501–600 of 1,001
A review on neuroimaging studies of genetic and environmental influences on early brain development
Gao, W., Grewen, K., Knickmeyer, R. C., Qiu, A., Salzwedel, A., Lin, W., & Gilmore, J. H. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2018.04.032 · Cited by 69
Bassett, A. S., & Costain, G. (2012) · The Application of Clinical Genetics · doi:10.2147/tacg.s21953 · Cited by 76
“This supports a more general mutational mechanism involving large rare CNV that substantially elevate risk for schizophrenia, especially more developmental forms of the disease.(3,182)”
BackgroundShan, D., Lucas, E. K., Drummond, J. B., Haroutunian, V., Meador-Woodruff, J. H., & McCullumsmith, R. E. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2012.12.019 · Cited by 69
CNV-WebStore: Online CNV Analysis, Storage and Interpretation
Vandeweyer, G., Reyniers, E., Wuyts, W. A., Rooms, L., & Kooy, R. F. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-4 · Cited by 76
“A small subset of specific CNVs is shown to associate with a wide spectrum of diseases [4-9].”
BackgroundMutant Mouse Models: Genotype-Phenotype Relationships to Negative Symptoms in Schizophrenia
O’Tuathaigh, C. M. P., Kirby, B. P., Moran, P. M., & Waddington, J. L. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp125 · Cited by 76
“variations each conferring risk for schizophrenia in relatively small numbers of cases.(106,129) It remains to be determined whether a plethora of genome-wide association studies will clarify or further confound these issues.”
BackgroundTabet, A., Verloès, A., Pilorge, M., Delaby, E., Delorme, R., Nygren, G., Devillard, F., Gérard, M., Passemard, S., Héron, D., et al. (2015) · Molecular Autism · doi:10.1186/s13229-015-0015-2 · Cited by 75
“individual in a schizophrenia cohort [51].”
Genetics in schizophrenia: where are we and what next?
Tiwari, A. K., Zai, C. C. H., Müller, D. J., & Kennedy, J. L. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.3/atiwari · Cited by 75
Genetic and cognitive windows into circuit mechanisms of psychiatric disease
Arguello, P. A., & Gogos, J. A. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.007 · Cited by 75
Marenne, G., Rodríguez‐Santiago, B., García‐Closas, M., Jurado, L. A. P., Rothman, N., Rico, D., Pita, G., Pisano, D. G., Kogevinas, M., Silverman, D. T., et al. (2010) · Human Mutation · doi:10.1002/humu.21398 · Cited by 75
Modeling psychiatric disorders through reprogramming
Brennand, K. J., & Gage, F. H. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.008268 · Cited by 65
“It is now believed that many rare but penetrant mutations contribute to ASDs and SCZD, and that hundreds of common variants with mild effects are shared by SCZD and bipolar disorder (O’Donovan et al., 2008; Walsh et al., 2008; Moskvina et al., 2009).”
BackgroundModels and Information-Theoretic Bounds for Nanopore Sequencing
Mao, W., Diggavi, S. N., & Kannan, S. (2018) · IEEE Transactions on Information Theory · doi:10.1109/tit.2018.2809001 · Cited by 75
“These repeated regions play an important role in evolution, development and in the genetics of many diseases [1]–[3].”
BackgroundThe role of genetics and genomics in clinical psychiatry
Hoehe, M. R., & Morris-Rosendahl, D. J. (2018) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2018.20.3/mhoehe · Cited by 66
Giaroli, G., Bass, N., Strydom, A., Rantell, K., & McQuillin, A. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.09.025 · Cited by 65
“Study Description of population Use of standardized measurement for diagnosis Screening of control group Validation experiments Use of historical control Likelihood of overlapping with previous studies (low, high) Walsh et al. (2008)”
InfluentialRegulation of Spine Formation by ErbB4 in PV-Positive Interneurons
Yin, D.-M., Sun, X.-D., Bean, J. C., Lin, T. W., Sathyamurthy, A., Xiong, W.-C., Gao, T.-M., Chen, Y.-J., & Mei, L. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2090-13.2013 · Cited by 67
“Reduced NRG1 protein levels and ErbB4 truncation mutants have been reported in patients with schizophrenia (Bertram et al., 2007; Walsh et al., 2008; Parlapani et al., 2010).”
BackgroundAn integrated genomic analysis of gene-function correlation on schizophrenia susceptibility genes
Chu, T., & Liu, Y. (2010) · Journal of Human Genetics · doi:10.1038/jhg.2010.24 · Cited by 74
Neurobiology and phenotypic expression in early onset schizophrenia
Vyas, N. S., Patel, N. H., & Puri, B. K. (2011) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2010.00253.x · Cited by 68
Large Copy-Number Variations Are Enriched in Cases With Moderate to Extreme Obesity
Wang, K., Li, W.-D., Glessner, J. T., Grant, S. F. A., Hakonarson, H., & Price, R. A. (2010) · Diabetes · doi:10.2337/db10-0192 · Cited by 67
Genetics of Schizophrenia: Ready to Translate?
Foley, C., Corvin, A. P., & Nakagome, S. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0807-5 · Cited by 75
Roles of glial cells in schizophrenia: Possible targets for therapeutic approaches
Takahashi, N., & Sakurai, T. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.11.001 · Cited by 67
The importance of long non-coding RNAs in neuropsychiatric disorders
Hosseini, E., Bagheri-Hosseinabadi, Z., De Toma, I., Jafarisani, M., & Sadeghi, I. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.07.004 · Cited by 70
MacCabe, J. H., Koupil, I., & Leon, D. A. (2009) · Psychological Medicine · doi:10.1017/s0033291709005431 · Cited by 64
“…how schizophrenia can persist in the population despite drastically reducing fertility ; even if there is strong selection pressure against these CNVs, this may be counterbalanced by a constant supply of new CNVs entering the population (Stefansson et al. 2008 ; Walsh et al. 2008 ; Xu et al. 2008).”
BackgroundSchizophrenia aetiology: Do gene-environment interactions hold the key?
The European Network of Schizophrenia Networks for the Study of Gene-Environment Interactions(EU-GEI) (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.04.003 · Cited by 73
Neurexin 1 (NRXN1) splice isoform expression during human neocortical development and aging
Jenkins, A. K., Paterson, C., Wang, Y., Hyde, T. M., Kleinman, J. E., & Law, A. J. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.107 · Cited by 62
Positron Emission Tomography in Schizophrenia: A New Perspective
Patel, N., Vyas, N. S., Puri, B. K., Nijran, K. S., & AL-NAHHAS, A. M. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.066076 · Cited by 73
“Higher burdens of deletions have been identified in childhood-onset schizophrenia (20%) than in adult-onset cases (15%) and healthy controls (5%) (45).”
BackgroundThe landscape of copy number variations in F innish families with autism spectrum disorders
Kanduri, C., Kantojärvi, K., Salo, P., Vanhala, R., Buck, G., Blancher, C., Lähdesmäki, H. J., & Järvelä, I. E. (2015) · Autism Research · doi:10.1002/aur.1502 · Cited by 72
“The interplay of glutathione metabolism pathway in conferring ASD risk has been widely documented and our findings confirm this (Buyske et al., 2006; Frustaci et al., 2012; Ghanizadeh et al., 2012; James et al., 2009; Rose et al., 2012; Serajee et al., 2004; Walsh et al., 2008; Wu et al., 2004).”
ResultThe use of race, ethnicity and ancestry in human genetic research
Ali-Khan, S. E., Krakowski, T., Tahir, R., & Daar, A. S. (2011) · The HUGO Journal · doi:10.1007/s11568-011-9154-5 · Cited by 60
Copy Number Variable MicroRNAs in Schizophrenia and Their Neurodevelopmental Gene Targets
Warnica, W. D., Merico, D., Costain, G., Alfred, S. E., Wei, J., Marshall, C. R., Scherer, S. W., & Bassett, A. S. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.011 · Cited by 72
Roth, B. L. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.012 · Cited by 73
“This interaction of caveolin-1 is interesting in light of a recent report that deletion of caveolin-1 is a rare genetic cause of schizophrenia (Walsh et al., 2008).”
BackgroundMoens, L. N., De Rijk, P., Reumers, J., Van Den Bossche, M. J. A., Glassee, W., De Zutter, S., Lenaerts, A.-S., Nordin, A., Nilsson, L.-G., Medina Castello, I., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023450 · Cited by 67
Li, H., Chou, S.-J., Hamasaki, T., Perez-Garcia, C. G., & O'Leary, D. D. (2012) · Neural Development · doi:10.1186/1749-8104-7-10 · Cited by 57
“These and other studies are beginning to reveal significant defects in neural structure and function resulting from a compromised NRG signaling pathway and may begin to provide insight into the potential relationship between ErbB-NRG signaling and schizophrenia, initially based upon the identification of Nrg1 and ErbB…”
BackgroundDrosophila as a Model Organism for the Study of Neuropsychiatric Disorders
O’Kane, C. J. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_110 · Cited by 73
“that are associated with the condition (Stefansson et al. 2008; The International Schizophrenia Consortium 2008; Walsh et al. 2008), and in the recent identification of large number of loci that make small contributions to disease susceptibility (Stefansson et al.”
BackgroundThe DGCR5 long noncoding RNA may regulate expression of several schizophrenia-related genes
Meng, Q., Wang, K., Brunetti, T. M., Xia, Y., Jiao, C., Dai, R., Fitzgerald, D., Thomas, A. F., Jay, L., Eckart, H., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat6912 · Cited by 71
“Some of these genes encode proteins involved in neurodevelopmental pathways including synaptic long-term potentiation and neuregulin signaling (7).”
Basing psychiatric classification on scientific foundation: Problems and prospects
Uher, R., & Rutter, M. (2012) · International Review of Psychiatry · doi:10.3109/09540261.2012.721346 · Cited by 66
“Perhaps the most remarkable discovery has been that a number of rare copy number variants (CNVs) are associated with autism, attention-defi cit/hyperactivity disorder and schizophrenia (Pinto et al., 2010; Walsh et al., 2008; Williams et al., 2010).”
BackgroundImplications of Genetic Findings for Understanding Schizophrenia
Owen, M. J. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs103 · Cited by 59
Why schizophrenia genetics needs epigenetics: a review.
Marić, N. P., & Švrakić, D. M. (2012) · PubMed · Cited by 71
Soler, J., Fañanás, L., Parellada, M., Krebs, M., Rouleau, G. A., & Fatjó‐Vilas, M. (2018) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.170066 · Cited by 71
Glutamate and dopamine components in schizophrenia
Seeman, P. (2009) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0919 · Cited by 54
Chen, S., Fuh, J., Chung, M., Lin, Y., Liao, Y., Wang, Y.-F., Hsu, C., Yang, U., Lin, M., Chiou, J.-J., et al. (2017) · Cephalalgia · doi:10.1177/0333102417695105 · Cited by 71
Danielson, E., Zhang, N., Metallo, J., Kaleka, K. S., Shin, S. M., Gerges, N. Z., & Lee, S. H. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0025-12.2012 · Cited by 70
Focus on HTR2C: A possible suggestion for genetic studies of complex disorders
Drago, A., & Serretti, A. (2009) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30864 · Cited by 64
“Indeed, it has recently been demonstrated that rare mutations are relevant to this topic [Walsh et al., 2008] and they should be considered along with a more classical statistical approach.”
BackgroundChen, H., Uddin, L. Q., Duan, X., Zheng, J., Long, Z., Zhang, Y., Guo, X., Zhang, Y., Zhao, J., & Chen, H. (2017) · Autism Research · doi:10.1002/aur.1834 · Cited by 71
“…molecules [Glessner et al., 2009; Need et al., 2009], gene DLG1, DLG2, DLGAP2, LRFN5, NRXN1,PCDH19, SHANK3, and TSPAN7, which regulate synaptic scaffolding, organization, and formation [Marshall et al., 2008; Walsh et al., 2008; Guilmatre et al., 2009; Pinto et al., 2010; Mitchell, 2011].”
Bertolino, A., & Blasi, G. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.04.038 · Cited by 70
Chang, H., Xiao, X., & Li, M. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.19 · Cited by 69
Molecular mechanisms of psychiatric diseases
Blokhin, I. O., Khorkova, O., Saveanu, R. V., & Wahlestedt, C. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105136 · Cited by 69
“5% of variance liability to SCZ (37), generating a possibility that the small odds ratios provided by GWAS are only due to very large meta-analytical sample sizes.”
BackgroundCurrent understanding of human genetics and genetic analysis of psoriasis
Oka, A., Mabuchi, T., OZAWA, A., & Inoko, H. (2012) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2012.01504.x · Cited by 69
Role of Copy Number Variants in Structural Birth Defects
Southard, A. E., Edelmann, L. J., & Gelb, B. D. (2012) · PEDIATRICS · doi:10.1542/peds.2011-2337 · Cited by 69
Creativity and Bipolar Disorder: A Shared Genetic Vulnerability
Greenwood, T. A. (2020) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050718-095449 · Cited by 69
“Rare structural and de novo variants have also been observed in schizophrenia patients (Rees et al. 2012, Walsh et al. 2008).”
BackgroundBuizer-Voskamp, J. E., Muntjewerff, J.-W., Strengman, E., Sabatti, C., Stefansson, H., Vorstman, J. A. S., & Ophoff, R. A. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.015 · Cited by 68
Recurrent reciprocal copy number variants: Roles and rules in neurodevelopmental disorders
Deshpande, A., & Weiss, L. A. (2018) · Developmental Neurobiology · doi:10.1002/dneu.22587 · Cited by 58
“…spectrum disorder (ASD), schizophrenia, bipo- lar disorder, attention deficit hyperactivity disorder (ADHD), seizures, and a range of other neurodevelop- mental problems (Walsh et al., 2008; Weiss et al., 2008; Zhang et al., 2009; Levy et al., 2011; Sanders et al., 2011; Malhotra and Sebat, 2012).”
BackgroundGenetic causality in schizophrenia and bipolar disorder: out with the old and in with the new
Porteous, D. J. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.07.005 · Cited by 68
Global Scientific Outputs of Schizophrenia Publications From 1975 to 2020: a Bibliometric Analysis
Kıraz, S., & Demir, E. (2021) · Psychiatric Quarterly · doi:10.1007/s11126-021-09937-4 · Cited by 67
Accurate Distinction of Pathogenic from Benign CNVs in Mental Retardation
Hehir‐Kwa, J. Y., Wieskamp, N., Webber, C., Pfundt, R., Brunner, H. G., Gilissen, C., Vries, B. B. A. D., Ponting, C. P., & Veltman, J. A. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000752 · Cited by 67
“This is of particular relevance because CNVs have recently been associated with other neurodevelopmental disorders such as autism and schizophrenia [1,4,5] but screening for causal CNVs in these diseases has yet to be implemented in most clinics.”
BackgroundAnalysis of mitochondrial DNA variants in Japanese patients with schizophrenia
Ueno, H., Nishigaki, Y., Kong, Q., Fuku, N., Kojima, S., Iwata, N., Ozaki, N., & Tanaka, M. (2009) · Mitochondrion · doi:10.1016/j.mito.2009.06.003 · Cited by 69
Frank, R. A. W., McRae, A. F., Pocklington, A. J., van de Lagemaat, L. N., Navarro, P., Croning, M. D. R., Komiyama, N. H., Bradley, S. J., Challiss, R. A. J., Armstrong, J. D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019011 · Cited by 64
“Recent genome-wide association studies (GWAS) of schizophrenia identified rare de novo copy number variation (CNV) [7] and an increased load of micro-deletions and micro-duplications around coding regions [8,9].”
BackgroundImaging genetics of schizophrenia
Meyer‐Lindenberg, A. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.4/amlindenberg · Cited by 67
“An important insight that has emerged from the last waves of genome-wide studies of schizophrenia concerns structural variations of the genome, where larger segments (up to several megabases) of genetic material are either duplicated (microduplications) or missing (microdeletions).(49,50) Convergent evidence now shows…”
Epigenetic signaling in schizophrenia
Ibi, D., & González-Maeso, J. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.06.003 · Cited by 61
5-HT6 Receptor: A New Player Controlling the Development of Neural Circuits
Dayer, A. G., Jacobshagen, M., Chaumont-Dubel, S., & Marin, P. (2015) · ACS Chemical Neuroscience · doi:10.1021/cn500326z · Cited by 58
Pers, T. H., Timshel, P., Ripke, S., Sullivan, P. F., O'Donovan, M. C., Franke, L., & Hirschhorn, J. N. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw007 · Cited by 59
“Large-scale studies of de novo variants, rare variants and common variants have implicated the postsynaptic density (PSD) (2–4), calcium channels (4–6), targets of the fragile X mental retardation protein (FMRP, product of FMR1) (3,4,7), targets of micro-RNA mir-137 (8), glutamate pathways (9), and processes related t…”
BackgroundGenetic Association Studies of Antioxidant Pathway Genes and Schizophrenia
Chowdari, K. V., Bamne, M. N., & Nimgaonkar, V. L. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3508 · Cited by 66
“Several novel models have recently been suggested, including rare variants such as copy-number variants (CNVs) (74), and possibly, methylation in specific chromosomal regions (48).”
BackgroundPhenotypic spectrum of NRXN1 mono‐ and bi‐allelic deficiency: A systematic review
Castronovo, P., Baccarin, M., Ricciardello, A., Picinelli, C., Tomaiuolo, P., Cucinotta, F., Frittoli, M., Lintas, C., Sacco, R., & Persico, A. M. (2020) · Clinical Genetics · doi:10.1111/cge.13537 · Cited by 65
Combining callers improves the detection of copy number variants from whole-genome sequencing
Coutelier, M., Holtgrewe, M., Jäger, M., Flöttmann, R., Mensah, M. A., Spielmann, M., Krawitz, P. M., Horn, D., Beule, D., & Mundlos, S. (2021) · European Journal of Human Genetics · doi:10.1038/s41431-021-00983-x · Cited by 65
“While array-based approaches have long been used to detect them in clinical practice, whole-genome sequencing (WGS) bears the promise to allow concomitant exploration of CNVs and smaller variants.”
BackgroundInfluentialFiksinski, A., Hoftman, G. D., Vorstman, J. A. S., & Bearden, C. E. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01783-5 · Cited by 65
“At present, more research is warranted to determine whether age of psychosis onset is truly earlier in 22q11DS, due to higher genetic burden [120] and biological vulnerability [121, 122], or a function of earlier detection due to ascertainment bias.”
BackgroundRare copy-number variants as modulators of common disease susceptibility
Auwerx, C., Lepamets, M., Sadler, M. C., Tesio, N., Ojavee, S. E., Clark, C. J., Mägi, R., Esko, T., Metspalu, A., Milani, L. A., et al. (2024) · Genome Medicine · doi:10.1186/s13073-023-01265-5 · Cited by 66
Lessons from Model Organisms: Phenotypic Robustness and Missing Heritability in Complex Disease
Queitsch, C., Carlson, K. D., & Girirajan, S. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003041 · Cited by 62
A Study of CNVs As Trait-Associated Polymorphisms and As Expression Quantitative Trait Loci
Gamazon, E. R., Nicolae, D. L., & Cox, N. J. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001292 · Cited by 55
Ortega, M. C., Bribián, A., Peregrín, S., Gil, M., Marín, Ó., & de Castro, F. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.03.015 · Cited by 66
Alaerts, M., & Del‐Favero, J. (2009) · Human Mutation · doi:10.1002/humu.21042 · Cited by 65
“…different CNV studies, such as APBA2 [ISC, 2008; Kirov et al., in press; Need et al., 2009], CHRNA7 [Stefansson et al., 2008; ISC, 2008], CNTNAP2 [ISC, 2008; Bi et al., 2009], GRM7 [Walsh et al., 2008; Bi et al., 2009], and NRXN1 [ISC, 2008; Walsh et al., 2008; Kirov et al., 2008; Bi et al., 2009].”
High resolution discovery and confirmation of copy number variants in 90 Yoruba Nigerians
Matsuzaki, H., Wang, P., Hu, J., Rava, R., & Fu, G. K. (2009) · Genome biology · doi:10.1186/gb-2009-10-11-r125 · Cited by 65
Schizophrenia: Treatment Targets Beyond Monoamine Systems
Ibrahim, H. M., & Tamminga, C. A. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105851 · Cited by 64
Bridging the Gap Between Modern Evolutionary Psychology and the Study of Individual Differences
Penke, L. (2010) · The Evolution of Personality and Individual Differences · doi:10.1093/acprof:oso/9780195372090.003.0009 · Cited by 56
Computational analysis of next generation sequencing data and its applications in clinical oncology
Wadapurkar, R. M., & Vyas, R. (2018) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2018.05.003 · Cited by 65
The role of the retinoids in schizophrenia: genomic and clinical perspectives
Reay, W. R., & Cairns, M. J. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0566-2 · Cited by 65
Non-caveolar caveolins – duties outside the caves
Pol, A., Morales-Paytuví, F., Bosch, M., & Parton, R. G. (2020) · Journal of Cell Science · doi:10.1242/jcs.241562 · Cited by 65
“, 2014), and interestingly, CAV1 gene disruption is considered to be a rare structural variant of schizophrenia (Walsh et al., 2008).”
BackgroundDUF1220 Domains, Cognitive Disease, and Human Brain Evolution
Dumas, L., & Sikela, J. M. (2009) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2009.74.025 · Cited by 61
“2004), schizophrenia (ISC 2008; Stefansson et al. 2008; Walsh et al. 2008; Need et al. 2009), microcephaly/macrocephaly (Brunetti-Pierri et al.”
Mutations in the NRG1 gene are associated with Hirschsprung disease
Tang, C. S.-M., Ngan, E., Tang, W.-K., So, M., Cheng, G., Miao, X., Leon, T. Y. Y., Leung, B. M.-C., Hui, K. J. W. S., Lui, V. C. H., et al. (2011) · Human Genetics · doi:10.1007/s00439-011-1035-4 · Cited by 64
The Psychosis Susceptibility Gene ZNF804A: Associations, Functions, and Phenotypes
Donohoe, G. J., Morris, D. W., & Corvin, A. P. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq080 · Cited by 64
McCullumsmith, R. E., O'Donovan, S. M., Drummond, J. B., Benesh, F., Simmons, M. S., Roberts, R. C., Lauriat, T. L., Haroutunian, V. H., & Meador‐Woodruff, J. H. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.148 · Cited by 64
Narla, S. T., Lee, Y. W., Benson, C. A., Sarder, P., Brennand, K., Stachowiak, E. K., & Stachowiak, M. K. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2016.12.012 · Cited by 64
“…variants in schizophrenia is an enrichment of those that are rare (b1% minor allele frequency) and large (N100 kb) CNVs (International Schizophrenia, 2008; Malhotra et al., 2011; Walsh et al., 2008), and those that occur de novo (Kirov et al., 2012; Malhotra et al., 2011; Xu et al., 2008).”
BackgroundRediscovering the value of families for psychiatric genetics research
Glahn, D. C., Nimgaonkar, V. L., Raventós, H., Rojas, J. C., McIntosh, A. M., Thomson, P. A., Jablensky, A. V., McCarthy, N. S., Charlesworth, J., Blackburn, N. B., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0073-x · Cited by 64
Multikernel Capsule Network for Schizophrenia Identification
Wang, T., Bezerianos, A., Cichocki, A., & Li, J. (2022) · IEEE Transactions on Cybernetics · doi:10.1109/tcyb.2020.3035282 · Cited by 63
“S CHIZOPHERNIA is among the most universal psychiatric disorders, affecting about 1% of the population worldwide [1], [2].”
Genomic Analysis of Mental Illness: A Changing Landscape
McClellan, J., & King, M.-C. (2010) · JAMA · doi:10.1001/jama.2010.869 · Cited by 63
Self-citationA Neurodevelopment Approach for a Transitional Model of Early Onset Schizophrenia
Berardis, D. D., Filippis, S. D., Masi, G., Vicari, S., & Zuddas, A. (2021) · Brain Sciences · doi:10.3390/brainsci11020275 · Cited by 63
“Rates of large, rare CNVs appear to be higher in COS patients compared to controls as well as to patients with AOS; 11.9% of COS probands were estimated to have a neurodevelopmental disease-associated CNV compared to 1.5% of their healthy siblings and 1.4–4.9% of AOS patients [27–29].”
BackgroundInfluentialRoussos, P., Giakoumaki, S. G., Adamaki, E., & Bitsios, P. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.009 · Cited by 63
Boone, P. M., Liu, P., Zhang, F., Carvalho, C. M. B., Towne, C. F., Batish, S. D., & Lupski, J. R. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3182106775 · Cited by 58
Melatonin as a potential therapeutic agent in psychiatric illness
Maldonado, M. D., Reiter, R. J., & Pérez‐San‐Gregorio, M. A. (2009) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1032 · Cited by 54
“Etiologically, the disorder is multifactorial and involves multiple genetic variants (Walsh et al., 2008) and environmental influences (Shao and Vawter, 2008).”
Brennand, K. J., Landek-Salgado, M. A., & Sawa, A. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.10.025 · Cited by 57
“Subjects with SZ are three times more likely to have genomic mutations that disrupt genes involved in neurodevelopmental pathways (14): single nucleotide polymorphisms and copy number variations (CNVs) have both been implicated in conferring risk of SZ.”
Olson, M. V. (2012) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090711-163825 · Cited by 58
“(120) found that rare CNVs affecting genomic regions of >100 kb were present in 15% of cases but only 5% of controls ( p < 0.”
BackgroundConsequences of NMDA Receptor Deficiency Can Be Rescued in the Adult Brain
Mielnik, C. A., Binko, M. A., Chen, Y., Funk, A. J., Johansson, E. M., Intson, K., Sivananthan, N., Islam, R., Milenkovic, M., Horsfall, W., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-020-00859-4 · Cited by 63
Genetics of Tardive Dyskinesia
Lee, H., & Kang, S. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-381328-2.00010-9 · Cited by 62
Hotspots of Large Rare Deletions in the Human Genome
Bradley, W. E. C., Raelson, J. V., Dubois, D. Y., Godin, É., Fournier, H., Privé, C., Allard, R., Pinchuk, V., Lapalme, M., Paulussen, R. J. A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009401 · Cited by 57
“The ultimate goal of this work was to detect genomic deletions potentially associated with disease, so we anticipated that the pertinent alterations might be rare, as has been found for schizophrenia (SZ)”
BackgroundGenome-wide copy number variation analysis in adult attention-deficit and hyperactivity disorder
Ramos‐Quiroga, J. A., Sánchez‐Mora, C., Casas, M., Iris Garcia-martinez, A., Bosch, R., Nogueira, M., Corrales, M., Palomar, G., Vidal, R., Coll-Tané, M., et al. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.10.022 · Cited by 62
“Recent work, however, strengthens the hypothesis that copy number variations (CNVs) encompassing relatively large genomic regions might contribute to the susceptibility of different psychiatric disorders such as ADHD (Kirov et al., 2008; Malhotra et al., 2011; Schizophrenia, 2008; Stefansson et al., 2008; Walsh et al.…”
BackgroundThe presentation of dermatoglyphic abnormalities in schizophrenia: A meta-analytic review
Golembo-Smith, S., Walder, D. J., Daly, M. P., Mittal, V. A., Kline, E. R., Reeves, G. M., & Schiffman, J. E. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.10.002 · Cited by 62
“…within the context of equifinality (Cicchetti and Rogosch, 1996) or as a series of subtypes, each the product of partially distinct and/or somewhat overlapping etiologies (Walsh et al., 2008; Gay et al., in press), may help to explain the heterogeneous findings noted in the present review.”
Autism spectrum disorder, developmental and psychiatric features in 16p11.2 duplication
on behalf of the Simons VIP consortium, Green Snyder, L., D’Angelo, D., Chen, Q., Bernier, R., Goin-Kochel, R. P., Wallace, A. S., Gerdts, J., Kanne, S., Berry, L., et al. (2016) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-016-2807-4 · Cited by 61
Synthetic associations in the context of genome-wide association scan signals
Orozco, G., Barrett, J. C., & Zeggini, E. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq368 · Cited by 61
“The same argument can also be extended to other forms of genetic variation, and it has been recently proposed that rare CNVs may be responsible for some fraction of the missing heritability of complex traits (44,45).”
BackgroundGenome-wide approaches to schizophrenia
Duan, J., Sanders, A. R., & Gejman, P. V. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.04.009 · Cited by 53
“[31].”
Liao, H.-M., Chao, Y.-L., Huang, A.-L., Cheng, M.-C., Chen, Y.-J., Lee, K.-F., Fang, J., Hsu, C.-H., & Chen, C. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.05.015 · Cited by 61
Imaging-Genetics in Autism Spectrum Disorder: Advances, Translational Impact, and Future Directions
Ameis, S. H., & Szatmari, P. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00046 · Cited by 45
A 25-year odyssey of genomic technology advances and structural variant discovery
Porubskỳ, D., & Eichler, E. E. (2024) · Cell · doi:10.1016/j.cell.2024.01.002 · Cited by 60
Self-citationvan Os, J., Lataster, T., Delespaul, P., Wichers, M., & Myin-Germeys, I. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086652 · Cited by 49
Risk architecture of schizophrenia: the role of epigenetics
Svrakic, D. M., Zorumski, C. F., Svrakic, N. M., Zwir, I., & Cloninger, C. R. (2013) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32835d8329 · Cited by 51
“Indeed, multiple candidate genes affecting GABA (GAD1 and RELN) and glutamate (G72, DAAO, SRR, GRM3, Neuregulin1-ErbB4, DNTP1) [32,41] have been implicated in schizophrenia.”
Background
Metadata
- Authors
- Walsh, T., McClellan, J. M., McCarthy, S. E., Addington, A. M., Pierce, S. B., Cooper, G. M., Nord, A. S., Kusenda, M., Malhotra, D., Bhandari, A., Stray, S. M., Rippey, C. F., Roccanova, P., Makarov, V., Lakshmi, B., Findling, R. L., Sikich, L., Stromberg, T., Merriman, B., Gogtay, N., Butler, P., Eckstrand, K., Noory, L., Gochman, P., Long, R., Chen, Z., Davis, S., Baker, C., Eichler, E. E., Meltzer, P. S., Nelson, S. F., Singleton, A. B., Lee, M. K., Rapoport, J. L., King, M.-C., & Sebat, J.
- Affiliations
- National Institutes of Health (US)
- Department of Medicine, University of Washington, Seattle, WA 98195, USA.
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Walsh, Tom
- McClellan, Jon M.
- McCarthy, Shane E.
- Addington, Anjené M.
- ORCID
- Walsh, Tom
- McClellan, Jon M.
- Addington, Anjené M.
- Pierce, Sarah B.
- Nord, Alex S.
- Malhotra, Dheeraj
- Bhandari, Abhishek
- Lakshmi, B.
- Findling, Robert L.
- Sikich, Linmarie
- Merriman, Barry
- Eckstrand, Kristen
- Gochman, Peter
- Davis, Sean
- Eichler, Evan E.
- Meltzer, Paul S.
- Singleton, Andrew B.
- Lee, Ming K.
- King, Mary-Claire
- Sebat, Jonathan
- Venue
- Science
- Published
- 2008-04-25
- Volume
- 320
- Issue
- 5875
- Pages
- 539-543
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2161641617
- Cited by
- 1,800
- References
- 42
- Citations by year
- 2026: 6 · 2025: 21 · 2024: 43 · 2023: 28 · 2022: 42 · 2021: 49 · 2020: 49 · 2019: 60 · 2018: 60 · 2017: 67 · 2016: 70 · 2015: 99 · 2014: 108 · 2013: 127 · 2012: 177
- FWCI
- 150.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health
- National Institute of Mental Health (MH061355, MH061464, MH061528, U01MH061355, U01MH061528, U01MH061464)
- National Institute of Neurological Disorders and Stroke (U24NS052108, NS052108)
- National Center for Research Resources (RR025014, RR-000046, UL1RR025014, M01RR000046)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD043569, R01HD043569)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- schizophrenia, structural variants, microdeletion, microduplication, brain development, neuregulin signaling, glutamate signaling, childhood schizophrenia, genetic association, copy number variation
- MeSH terms
- Adolescent, Adult, Amino Acid Sequence, Brain, Child, Female, Humans, Male, Molecular Sequence Data, Mutation, Neurons, Schizophrenia, Signal Transduction, Genome, Human, Case-Control Studies, Gene Deletion, Age of Onset, Genetic Predisposition to Disease, Oligonucleotide Array Sequence Analysis, Gene Duplication, Polymorphism, Single Nucleotide, Excitatory Amino Acid Transporter 1, ErbB Receptors, Receptor, ErbB-4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.